Tapewire

NYSE · USD

MET

METLIFE INC

Export transactions ↓
Tapewire entity
488
SEC CIK
0001099219
Parsed reports
1,091

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2026 Filed Oct 5, 2026 20:05 UTC GrantCommon Stock 544 $94.35 $51,326.40
Disclosure

SEC source: 0001707516-26-000015 · wk-form4_1791230743.xml · nonDerivative · entry 1

Johnson Jeh C. · CIK 0001707516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,101

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:05 UTC GrantCommon Stock 941 $94.35 $88,783.35
Disclosure

SEC source: 0001283051-26-000015 · wk-form4_1791230735.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,132

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:05 UTC GrantCommon Stock 544 $94.35 $51,326.40
Disclosure

SEC source: 0002066326-26-000015 · wk-form4_1791230727.xml · nonDerivative · entry 1

Mumenthaler Christian Stephane · CIK 0002066326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,018

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:05 UTC GrantCommon Stock 544 $94.35 $51,326.40
Disclosure

SEC source: 0001707351-26-000025 · wk-form4_1791230707.xml · nonDerivative · entry 1

Harris Carla A · CIK 0001707351 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,701

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:05 UTC GrantCommon Stock 544 $0.00 $0.00
Disclosure

SEC source: 0001785997-26-000010 · wk-form4_1791230699.xml · nonDerivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,932

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:04 UTC GrantCommon Stock 544 $94.35 $51,326.40
Disclosure

SEC source: 0001754648-26-000015 · wk-form4_1791230692.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,929

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:04 UTC GrantCommon Stock 544 $0.00 $0.00
Disclosure

SEC source: 0001836301-26-000020 · wk-form4_1791230684.xml · nonDerivative · entry 1

Seitz Michelle · CIK 0001836301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,125

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:04 UTC
Hay Laura JDirector
GrantCommon Stock 544 $94.35 $51,326.40
Disclosure

SEC source: 0002013372-26-000016 · wk-form4_1791230677.xml · nonDerivative · entry 1

Hay Laura J · CIK 0002013372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,901

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:04 UTC GrantCommon Stock 544 $94.35 $51,326.40
Disclosure

SEC source: 0001198236-26-000015 · wk-form4_1791230666.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,248

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:04 UTC GrantCommon Stock 544 $94.35 $51,326.40
Disclosure

SEC source: 0001420864-26-000024 · wk-form4_1791230671.xml · nonDerivative · entry 1

Glaser Daniel S · CIK 0001420864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,249

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 20:02 UTC
TADROS RAMYPresident, U.S. Business
GrantCommon Stock 115 $95.50 $10,982.50
Disclosure

SEC source: 0001714199-26-000011 · wk-form4_1789070562.xml · nonDerivative · entry 1

TADROS RAMY · CIK 0001714199 · President, U.S. Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,695

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 20:02 UTC GrantCommon Stock 21 $95.50 $2,005.50
Disclosure

SEC source: 0002066326-26-000013 · wk-form4_1789070551.xml · nonDerivative · entry 1

Mumenthaler Christian Stephane · CIK 0002066326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,474

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 20:02 UTC GrantCommon Stock 42 $95.50 $4,011.00
Disclosure

SEC source: 0001707351-26-000020 · wk-form4_1789070540.xml · nonDerivative · entry 1

Harris Carla A · CIK 0001707351 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,157

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 20:02 UTC
Hay Laura JDirector
GrantCommon Stock 39 $95.50 $3,724.50
Disclosure

SEC source: 0002013372-26-000014 · wk-form4_1789070545.xml · nonDerivative · entry 1

Hay Laura J · CIK 0002013372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,357

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 20:02 UTC GrantCommon Stock 294 $95.50 $28,077.00
Disclosure

SEC source: 0001198236-26-000013 · wk-form4_1789070557.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,704

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 20:02 UTC GrantCommon Stock 157 $95.50 $14,993.50
Disclosure

SEC source: 0001754648-26-000013 · wk-form4_1789070521.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,385

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 20:02 UTC GrantCommon Stock 618 $95.50 $59,019.00
Disclosure

SEC source: 0001283051-26-000013 · wk-form4_1789070532.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,191

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 20:02 UTC GrantCommon Stock 59 $95.50 $5,634.50
Disclosure

SEC source: 0001707516-26-000013 · wk-form4_1789070527.xml · nonDerivative · entry 1

Johnson Jeh C. · CIK 0001707516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,557

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 20:01 UTC GrantCommon Stock 10 $95.50 $955.00
Disclosure

SEC source: 0001420864-26-000022 · wk-form4_1789070515.xml · nonDerivative · entry 1

Glaser Daniel S · CIK 0001420864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,705

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
August 31, 2026 Filed Sep 2, 2026 20:18 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Tax withholdingCommon Stock 4,030 $95.17 $383,535.10
Disclosure

SEC source: 0001770295-26-000011 · wk-form4_1788380321.xml · nonDerivative · entry 1

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,350

F1 · kind: Withheld for taxes on shares issued for restricted stock units.

Read SEC document
August 31, 2026 Filed Sep 2, 2026 20:18 UTC
TADROS RAMYPresident, U.S. Business
Tax withholdingCommon Stock 4,366 $95.17 $415,512.22
Disclosure

SEC source: 0001714199-26-000009 · wk-form4_1788380315.xml · nonDerivative · entry 1

TADROS RAMY · CIK 0001714199 · President, U.S. Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,580

F1 · kind: Withheld for taxes on shares issued for restricted stock units.

Read SEC document
August 31, 2026 Filed Sep 2, 2026 20:18 UTC
McCallion John D.EVP & Chief Financial Officer
Tax withholdingCommon Stock 6,057 $95.17 $576,444.69
Disclosure

SEC source: 0001709116-26-000007 · wk-form4_1788380327.xml · nonDerivative · entry 1

McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 269,137

F1 · kind: Withheld for taxes on shares issued for restricted stock units.

Read SEC document
August 31, 2026 Filed Sep 2, 2026 20:18 UTC
PAPPAS BILLEVP, Global Tech. & Ops.
Tax withholdingCommon Stock 4,030 $95.17 $383,535.10
Disclosure

SEC source: 0001787586-26-000007 · wk-form4_1788380331.xml · nonDerivative · entry 1

PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,716

F1 · kind: Withheld for taxes on shares issued for restricted stock units.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:13 UTC GrantCommon Stock 587 $87.40 $51,303.80
Disclosure

SEC source: 0002066326-26-000011 · wk-form4_1781813587.xml · nonDerivative · entry 1

Mumenthaler Christian Stephane · CIK 0002066326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,452

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:13 UTC GrantCommon Stock 587 $87.40 $51,303.80
Disclosure

SEC source: 0001198236-26-000011 · wk-form4_1781813579.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,410

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:12 UTC GrantCommon Stock 587 $87.40 $51,303.80
Disclosure

SEC source: 0001707516-26-000011 · wk-form4_1781813571.xml · nonDerivative · entry 1

Johnson Jeh C. · CIK 0001707516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,498

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:12 UTC GrantCommon Stock 587 $87.40 $51,303.80
Disclosure

SEC source: 0001754648-26-000011 · wk-form4_1781813553.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,229

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:12 UTC
Hay Laura JDirector
GrantCommon Stock 587 $87.40 $51,303.80
Disclosure

SEC source: 0002013372-26-000012 · wk-form4_1781813532.xml · nonDerivative · entry 1

Hay Laura J · CIK 0002013372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,318

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:12 UTC GrantCommon Stock 1,016 $87.40 $88,798.40
Disclosure

SEC source: 0001283051-26-000011 · wk-form4_1781813527.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,573

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:12 UTC GrantCommon Stock 587 $87.40 $51,303.80
Disclosure

SEC source: 0001707351-26-000016 · wk-form4_1781813520.xml · nonDerivative · entry 1

Harris Carla A · CIK 0001707351 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,115

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:11 UTC GrantCommon Stock 587 $0.00 $0.00
Disclosure

SEC source: 0001836301-26-000016 · wk-form4_1781813514.xml · nonDerivative · entry 1

Seitz Michelle · CIK 0001836301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,581

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:11 UTC GrantCommon Stock 587 $87.40 $51,303.80
Disclosure

SEC source: 0001420864-26-000020 · wk-form4_1781813506.xml · nonDerivative · entry 1

Glaser Daniel S · CIK 0001420864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,695

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:11 UTC GrantCommon Stock 587 $0.00 $0.00
Disclosure

SEC source: 0001785997-26-000008 · wk-form4_1781813500.xml · nonDerivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,388

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:02 UTC GrantCommon Stock 169 $85.57 $14,461.33
Disclosure

SEC source: 0001754648-26-000009 · wk-form4_1781208168.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,642

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:02 UTC GrantCommon Stock 322 $85.57 $27,553.54
Disclosure

SEC source: 0001198236-26-000009 · wk-form4_1781208163.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,823

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:02 UTC
Hay Laura JDirector
GrantCommon Stock 39 $85.57 $3,337.23
Disclosure

SEC source: 0002013372-26-000010 · wk-form4_1781208157.xml · nonDerivative · entry 1

Hay Laura J · CIK 0002013372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,731

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:02 UTC GrantCommon Stock 61 $85.57 $5,219.77
Disclosure

SEC source: 0001707516-26-000009 · wk-form4_1781208151.xml · nonDerivative · entry 1

Johnson Jeh C. · CIK 0001707516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,911

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:02 UTC GrantCommon Stock 42 $85.57 $3,593.94
Disclosure

SEC source: 0001707351-26-000014 · wk-form4_1781208145.xml · nonDerivative · entry 1

Harris Carla A · CIK 0001707351 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,528

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:02 UTC GrantCommon Stock 20 $85.57 $1,711.40
Disclosure

SEC source: 0002066326-26-000009 · wk-form4_1781208139.xml · nonDerivative · entry 1

Mumenthaler Christian Stephane · CIK 0002066326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,865

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:02 UTC GrantCommon Stock 7 $85.57 $598.99
Disclosure

SEC source: 0001420864-26-000018 · wk-form4_1781208133.xml · nonDerivative · entry 1

Glaser Daniel S · CIK 0001420864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,108

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:02 UTC GrantCommon Stock 678 $85.57 $58,016.46
Disclosure

SEC source: 0001283051-26-000009 · wk-form4_1781208127.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,557

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:02 UTC
TADROS RAMYPresident, U.S. Business
GrantCommon Stock 127 $85.57 $10,867.39
Disclosure

SEC source: 0001714199-26-000007 · wk-form4_1781208121.xml · nonDerivative · entry 1

TADROS RAMY · CIK 0001714199 · President, U.S. Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,946

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:07 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Exercise / conversionEmployee Stock Options (right to buy) · Derivative 10,712 $0.00 Strike: $45.50 $0.00
Disclosure

SEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · derivative · entry 5

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,712 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options became exercisable in three substantially equal installments on March 2, 2019, 2020, and 2021.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:07 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Exercise / conversionEmployee Stock Options (right to buy) · Derivative 10,600 $0.00 Strike: $46.85 $0.00
Disclosure

SEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · derivative · entry 4

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,600 shares

Expires 2027-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:07 UTC
DEBEL MARLENEEVP & Chief Risk Officer
SaleCommon Stock 21,312 $81.59 $1,738,822.64
Disclosure

SEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · nonDerivative · entry 3

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,380

F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $81.57 to $81.65, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:07 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Exercise / conversionCommon Stock 10,712 $45.50 $487,396.00
Disclosure

SEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · nonDerivative · entry 2

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,692

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:07 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Exercise / conversionCommon Stock 10,600 $46.85 $496,610.00
Disclosure

SEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · nonDerivative · entry 1

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 30, 2026 Filed May 4, 2026 20:06 UTC
O'Neill Adrienne KarenEVP & Chief Accounting Officer
GrantCommon Stock 12,485 Not disclosed Not disclosed
Disclosure

SEC source: 0002083481-26-000006 · wk-form4_1777925165.xml · nonDerivative · entry 1

O'Neill Adrienne Karen · CIK 0002083481 · EVP & Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,042

F1 · price: Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:05 UTC GrantCommon Stock 721 $71.17 $51,313.57
Disclosure

SEC source: 0001707351-26-000011 · wk-form4_1775246736.xml · nonDerivative · entry 1

Harris Carla A · CIK 0001707351 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,485

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:05 UTC GrantCommon Stock 721 $0.00 $0.00
Disclosure

SEC source: 0001836301-26-000009 · wk-form4_1775246728.xml · nonDerivative · entry 1

Seitz Michelle · CIK 0001836301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 994

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.